125 related articles for article (PubMed ID: 12437107)
21. Evolutionary lines of cysteine peptidases.
Barrett AJ; Rawlings ND
Biol Chem; 2001 May; 382(5):727-33. PubMed ID: 11517925
[TBL] [Abstract][Full Text] [Related]
22. Proteinases participating in the processing and activation of prolegumain in primary cultured rat macrophages.
Lecaille F; Muno D; Kominami E; Ishidoh K
Biol Chem; 2004 Jun; 385(6):511-6. PubMed ID: 15255183
[TBL] [Abstract][Full Text] [Related]
23. Potent and selective ketoamide-based inhibitors of cysteine protease, cathepsin K.
Tavares FX; Deaton DN; Miller AB; Miller LR; Wright LL; Zhou HQ
J Med Chem; 2004 Oct; 47(21):5049-56. PubMed ID: 15456248
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and SAR of succinamide peptidomimetic inhibitors of cathepsin S.
Chatterjee AK; Liu H; Tully DC; Guo J; Epple R; Russo R; Williams J; Roberts M; Tuntland T; Chang J; Gordon P; Hollenbeck T; Tumanut C; Li J; Harris JL
Bioorg Med Chem Lett; 2007 May; 17(10):2899-903. PubMed ID: 17382545
[TBL] [Abstract][Full Text] [Related]
25. Specificity of aza-peptide electrophile activity-based probes of caspases.
Sexton KB; Kato D; Berger AB; Fonovic M; Verhelst SH; Bogyo M
Cell Death Differ; 2007 Apr; 14(4):727-32. PubMed ID: 17170749
[TBL] [Abstract][Full Text] [Related]
26. Novel cell-permeable acyloxymethylketone inhibitors of asparaginyl endopeptidase.
Loak K; Li DN; Manoury B; Billson J; Morton F; Hewitt E; Watts C
Biol Chem; 2003 Aug; 384(8):1239-46. PubMed ID: 12974392
[TBL] [Abstract][Full Text] [Related]
27. Design and evaluation of inhibitors for dipeptidyl peptidase I (Cathepsin C).
Kam CM; Götz MG; Koot G; McGuire M; Thiele D; Hudig D; Powers JC
Arch Biochem Biophys; 2004 Jul; 427(2):123-34. PubMed ID: 15196986
[TBL] [Abstract][Full Text] [Related]
28. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
[TBL] [Abstract][Full Text] [Related]
29. Intra- and extracellular regulation of activity and processing of legumain by cystatin E/M.
Smith R; Johansen HT; Nilsen H; Haugen MH; Pettersen SJ; Mælandsmo GM; Abrahamson M; Solberg R
Biochimie; 2012 Dec; 94(12):2590-9. PubMed ID: 22902879
[TBL] [Abstract][Full Text] [Related]
30. Detailed biochemical characterization of human placental cystatin (HPC).
Rashid F; Sharma S; Bano B
Placenta; 2006 Aug; 27(8):822-31. PubMed ID: 16271758
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of a novel legumain-cleavable colchicine prodrug with cell-specific toxicity.
Smith RL; Åstrand OA; Nguyen LM; Elvestrand T; Hagelin G; Solberg R; Johansen HT; Rongved P
Bioorg Med Chem; 2014 Jul; 22(13):3309-15. PubMed ID: 24842619
[TBL] [Abstract][Full Text] [Related]
32. Down-regulation of human extracellular cysteine protease inhibitors by the secreted staphylococcal cysteine proteases, staphopain A and B.
Vincents B; Onnerfjord P; Gruca M; Potempa J; Abrahamson M
Biol Chem; 2007 Apr; 388(4):437-46. PubMed ID: 17391065
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, and
Corrigan TS; Lotti Diaz LM; Border SE; Ratigan SC; Kasper KQ; Sojka D; Fajtova P; Caffrey CR; Salvesen GS; McElroy CA; Hadad CM; Doğan Ekici Ö
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1387-1402. PubMed ID: 32633155
[TBL] [Abstract][Full Text] [Related]
34. Interaction of papain-like cysteine proteases with dipeptide-derived nitriles.
Löser R; Schilling K; Dimmig E; Gütschow M
J Med Chem; 2005 Dec; 48(24):7688-707. PubMed ID: 16302809
[TBL] [Abstract][Full Text] [Related]
35. Peptidyl fluoromethyl ketones as thiol protease inhibitors.
Shaw E; Angliker H; Rauber P; Walker B; Wikstrom P
Biomed Biochim Acta; 1986; 45(11-12):1397-403. PubMed ID: 2953336
[TBL] [Abstract][Full Text] [Related]
36. Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase.
Chen JM; Dando PM; Rawlings ND; Brown MA; Young NE; Stevens RA; Hewitt E; Watts C; Barrett AJ
J Biol Chem; 1997 Mar; 272(12):8090-8. PubMed ID: 9065484
[TBL] [Abstract][Full Text] [Related]
37. Arylaminoethyl carbamates as a novel series of potent and selective cathepsin S inhibitors.
Tully DC; Liu H; Chatterjee AK; Alper PB; Williams JA; Roberts MJ; Mutnick D; Woodmansee DH; Hollenbeck T; Gordon P; Chang J; Tuntland T; Tumanut C; Li J; Harris JL; Karanewsky DS
Bioorg Med Chem Lett; 2006 Oct; 16(19):5107-11. PubMed ID: 16876407
[TBL] [Abstract][Full Text] [Related]
38. New potent cathepsin G phosphonate inhibitors.
Sieńczyk M; Lesner A; Wysocka M; Legowska A; Pietrusewicz E; Rolka K; Oleksyszyn J
Bioorg Med Chem; 2008 Oct; 16(19):8863-7. PubMed ID: 18805698
[TBL] [Abstract][Full Text] [Related]
39. Longer wavelength fluorescence resonance energy transfer depsipeptide substrates for hepatitis C virus NS3 protease.
Konstantinidis AK; Richardson PL; Kurtz KA; Tripathi R; Chen CM; Huang P; Randolph J; Towne D; Donnelly J; Warrior U; Middleton T; Kati WM
Anal Biochem; 2007 Sep; 368(2):156-67. PubMed ID: 17644059
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
